Clinical Pharmacist Interventions in Adults With Sepsis and Septic Shock: A Scoping Review
Cureus · 16.11.2026
DOI: 10.7759/cureus.119740 ↗Kurz gefasst
Scoping Review in der Zeitschrift Cureus, erschienen am 16.11.2026. Verfasst von Esteban Zavaleta-Monestel und 4 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben.
Themen: Sepsis
Abstract (Originalsprache)
Clinical pharmacists may contribute to several stages of sepsis management, although interventions and reported outcomes vary across clinical settings. This scoping review aimed to map clinical pharmacist interventions among adults with suspected or confirmed sepsis or septic shock receiving hospital-based acute care and to characterize associated process, stewardship, medication-safety, and clinical outcomes. Guided by Joanna Briggs Institute methodology and the PRISMA extension for scoping reviews, we searched PubMed/MEDLINE, ScienceDirect, and Google Scholar in March 2026 for English- or Spanish-language publications from 2016 through 2025. The search identified 1,482 records; 1,306 were screened, and 235 reports underwent full-text assessment. The final synthesis included eight primary studies and one systematic review, interpreted separately because of overlapping primary evidence. Interventions encompassed early antimicrobial review, participation in sepsis response teams, protocol-guided treatment decisions, antimicrobial optimization, and structured medication review. Across the primary studies, favorable findings were reported for antimicrobial appropriateness and selected measures of treatment timeliness. Some studies also reported favorable antimicrobial stewardship and medication-safety outcomes, although adverse drug reactions and drug-related problems represented distinct measures. No statistically significant improvement in mortality or length of stay was demonstrated in the comparative studies assessing these outcomes. The findings suggest that clinical pharmacist involvement may improve selected aspects of pharmacotherapeutic care in sepsis, but differences in intervention models, study designs, and outcome definitions limit causal interpretation and generalizability. Future multicenter studies should evaluate clearly defined pharmacist roles, appropriate comparators, and patient-centered outcomes.
Zitieren
APA
Zavaleta-Monestel, E., Torres-Mora, K. R., Mora-Jiménez, J., Gamboa, J. A. C., & Díaz-Madriz, J. P. (2026). Clinical Pharmacist Interventions in Adults With Sepsis and Septic Shock: A Scoping Review. Cureus. https://doi.org/10.7759/cureus.119740
Vancouver
Zavaleta-Monestel E, Torres-Mora KR, Mora-Jiménez J, Gamboa JAC, Díaz-Madriz JP. Clinical Pharmacist Interventions in Adults With Sepsis and Septic Shock: A Scoping Review. Cureus. 2026. doi:10.7759/cureus.119740
BibTeX
@article{ZavaletaMonestel2026,
author = {Zavaleta-Monestel, Esteban and Torres-Mora, Kimberly R and Mora-Jiménez, Jeaustin and Gamboa, José A Castro and Díaz-Madriz, José Pablo},
title = {Clinical Pharmacist Interventions in Adults With Sepsis and Septic Shock: A Scoping Review},
journal = {Cureus},
year = {2026},
doi = {10.7759/cureus.119740}
}
EUVIMED